PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function
Status:
Completed
Trial end date:
2020-05-09
Target enrollment:
Participant gender:
Summary
The purpose of this international study was to assess the effect of varying degrees of
impaired hepatic function compared to a normal hepatic function (Child-Pugh classification)
on the pharmacokinetics and safety of midostaurin.